[Re-resection for recurrent intrahepatic cholangiocarcinoma]
Sae Murakami1, Tetsuo Ajiki, Taro Okazaki
1Dept. of Surgery, Division of Hepato-Biliary-Pancreatic Surgery, Kobe University Graduate School of Medicine.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|March 4, 2015
Summary
For recurrent intrahepatic cholangiocarcinoma (IHC), re-resection or chemotherapy significantly improves survival compared to best supportive care. Re-resection is particularly effective for intrahepatic-only recurrence, offering prolonged survival benefits.
Area of Science:
- Hepatobiliary surgery
- Surgical oncology
- Gastroenterology


